Subcutaneous NTG for US Radial Artery Cannulation

Not Applicable

Completed

• Conditions: Morbid Obesity
• Interventions: Drug: Subcutaneous saline; Drug: Subcutaneous nitroglycrin

• Registration Number: NCT03006640
• Lead Sponsor: AlRefaey Kandeel

Brief Summary

Clinicians are increasingly dealing with morbid obese patients. In morbid obese patients, difficult sampling and problems encountered with noninvasive blood pressure monitoring makes arterial cannulation an essential skill in many situations like surgeries or trans-radial procedures for coronary or carotid interventions.

Radial artery has been preferred over other sites for arterial cannulation due to low incidence of bleeding, better hemostats, more comfort, and immediate ambulation. sm In this study, subcutaneous nitroglycerin will be used to facilitate radial artery cannulation aiming to decrease insertion time, increase success rate and decrease related complications

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01
• Primary Completion: 2016-06
• Study Completion: 2016-11
• Status Verified: 2016-12
• Study First Submitted: 2016-12-27
• Study First Submitted QC: 2016-12-27
• Last Update Submitted: 2016-12-27
• Study First Posted: 2016-12-30
• Last Update Posted: 2016-12-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• morbid obese indicated for radial artery cannuulation

Exclusion Criteria

• +ve allen test peripheral arterial disease refusal

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control group	Subcutaneous saline	-
NTG group	Subcutaneous nitroglycrin	-

Primary Outcome Measures

Name	Time	Method
Success rate	24 hours after surgery